ArticleBiomedicines2026

The Impact of Angiotensin-Converting Enzyme Inhibitors on Immune-Related Adverse Events and Clinical Outcomes in Patients with Metastatic NSCLC.

Noa Shani Shrem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.